Suppr超能文献

相似文献

1
Innate immunity and HBV persistence.
Curr Opin Virol. 2021 Aug;49:13-20. doi: 10.1016/j.coviro.2021.04.003. Epub 2021 May 13.
3
Adaptive immunity in HBV infection.
J Hepatol. 2016 Apr;64(1 Suppl):S71-S83. doi: 10.1016/j.jhep.2016.01.026.
4
The role of innate immunity in the immunopathology and treatment of HBV infection.
J Hepatol. 2016 Apr;64(1 Suppl):S60-S70. doi: 10.1016/j.jhep.2016.01.028.
5
Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
ACS Infect Dis. 2019 May 10;5(5):703-712. doi: 10.1021/acsinfecdis.8b00297. Epub 2019 Apr 3.
6
HBV and the immune response.
Liver Int. 2015 Jan;35 Suppl 1:121-8. doi: 10.1111/liv.12749.
7
Innate and adaptive immune responses in hepatitis B virus infection.
Dig Dis. 2010;28(1):126-32. doi: 10.1159/000282075. Epub 2010 May 7.
8
Immunopathogenesis of chronic hepatitis B.
World J Gastroenterol. 2014 Oct 21;20(39):14156-71. doi: 10.3748/wjg.v20.i39.14156.
9
Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:132-7. doi: 10.1111/jgh.12034.
10
Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy.
J Hepatol. 2016 Mar;64(3):539-46. doi: 10.1016/j.jhep.2015.10.013. Epub 2015 Oct 24.

引用本文的文献

1
3
Contradictory Mechanisms of rheumatoid arthritis and hepatitis B virus infection activation.
Heliyon. 2024 Dec 26;11(1):e41444. doi: 10.1016/j.heliyon.2024.e41444. eCollection 2025 Jan 15.
4
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.
Pathogens. 2024 Sep 5;13(9):766. doi: 10.3390/pathogens13090766.
6
Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.
Front Immunol. 2024 Mar 13;15:1363996. doi: 10.3389/fimmu.2024.1363996. eCollection 2024.
7
RDW-SD is Superior to RDW-CV in Reflecting Liver Fibrosis Stage in Patients with Chronic Hepatitis B.
Infect Drug Resist. 2023 Oct 27;16:6881-6891. doi: 10.2147/IDR.S427047. eCollection 2023.
8
[Interferon-related gene array in predicting the efficacy of interferon therapy in chronic hepatitis B].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023 Feb 25;40(1):79-86. doi: 10.7507/1001-5515.202301014.
9
Resident macrophages of the lung and liver: The guardians of our tissues.
Front Immunol. 2022 Nov 30;13:1029085. doi: 10.3389/fimmu.2022.1029085. eCollection 2022.
10
Advances in Immunotherapy for Hepatitis B.
Pathogens. 2022 Sep 28;11(10):1116. doi: 10.3390/pathogens11101116.

本文引用的文献

1
Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis B.
Hepatology. 2021 Oct;74(4):1737-1749. doi: 10.1002/hep.31795. Epub 2021 Sep 14.
3
Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes.
iScience. 2021 Jan 4;24(1):101969. doi: 10.1016/j.isci.2020.101969. eCollection 2021 Jan 22.
5
Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition.
Nat Commun. 2021 Jan 4;12(1):98. doi: 10.1038/s41467-020-20316-8.
7
Mucosal-Associated Invariant T Cell Dysregulation Correlates With Conjugated Bilirubin Level in Chronic HBV Infection.
Hepatology. 2021 May;73(5):1671-1687. doi: 10.1002/hep.31602. Epub 2021 Mar 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验